Schedule 13D ownership disclosure

AgomAb Therapeutics NV

Common Shares, no nominal value per share ("Common Shares") · CUSIP: 00860C102

Event date: 2026-02-09

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • LSP 7 Cooperatieve U.A.Reported CIK 0001876264

    Shares: 5,141,992 · Class: 10.6%

  • LSP 7 Management B.V.

    Shares: 5,141,992 · Class: 10.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-26-052946
Form type
SCHEDULE 13D
Filer
Agomab Therapeutics NV
CIK
CIK 2020932
Filed
Feb 17, 2026
Reporting period
Feb 09, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub